SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65,887 | -34.3% | 68,632 | -48.7% | 0.00% | – |
| Q1 2023 | $100,346 | +92.8% | 133,795 | -5.2% | 0.00% | – |
| Q4 2022 | $52,035 | -13.3% | 141,207 | +1.1% | 0.00% | – |
| Q3 2022 | $60,000 | -7.7% | 139,607 | +66.9% | 0.00% | – |
| Q2 2022 | $65,000 | -35.6% | 83,661 | +6.7% | 0.00% | – |
| Q1 2022 | $101,000 | +98.0% | 78,418 | +94.0% | 0.00% | – |
| Q4 2021 | $51,000 | -65.3% | 40,418 | -39.9% | 0.00% | – |
| Q3 2021 | $147,000 | +47.0% | 67,262 | +152.8% | 0.00% | – |
| Q2 2021 | $100,000 | -22.5% | 26,605 | -32.7% | 0.00% | – |
| Q1 2021 | $129,000 | +1190.0% | 39,514 | +1217.6% | 0.00% | – |
| Q4 2020 | $10,000 | -52.4% | 2,999 | -41.1% | 0.00% | – |
| Q3 2020 | $21,000 | -79.6% | 5,095 | -83.3% | 0.00% | – |
| Q2 2020 | $103,000 | +586.7% | 30,536 | +370.9% | 0.00% | – |
| Q1 2020 | $15,000 | -97.5% | 6,484 | -96.0% | 0.00% | -100.0% |
| Q4 2019 | $590,000 | +217.2% | 162,146 | +624.4% | 0.00% | +100.0% |
| Q3 2019 | $186,000 | +313.3% | 22,382 | +331.1% | 0.00% | – |
| Q4 2018 | $45,000 | -86.0% | 5,192 | -72.8% | 0.00% | -100.0% |
| Q3 2018 | $321,000 | +43.9% | 19,106 | +79.8% | 0.00% | +50.0% |
| Q2 2018 | $223,000 | +291.2% | 10,624 | +201.3% | 0.00% | +100.0% |
| Q1 2018 | $57,000 | -31.3% | 3,526 | -19.4% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | +80.4% | 4,375 | -38.7% | 0.00% | 0.0% |
| Q1 2017 | $46,000 | -17.9% | 7,138 | -43.3% | 0.00% | 0.0% |
| Q4 2016 | $56,000 | -5.1% | 12,580 | +0.4% | 0.00% | 0.0% |
| Q3 2016 | $59,000 | -16.9% | 12,533 | +16.7% | 0.00% | 0.0% |
| Q2 2016 | $71,000 | -21.1% | 10,737 | -28.8% | 0.00% | 0.0% |
| Q3 2015 | $90,000 | -61.4% | 15,072 | -60.7% | 0.00% | -75.0% |
| Q1 2015 | $233,000 | -13.4% | 38,386 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $269,000 | +13.0% | 38,808 | +33.0% | 0.00% | 0.0% |
| Q3 2014 | $238,000 | +67.6% | 29,187 | +67.4% | 0.00% | +100.0% |
| Q2 2014 | $142,000 | -8.4% | 17,435 | -11.8% | 0.00% | -33.3% |
| Q1 2014 | $155,000 | -21.3% | 19,764 | -11.2% | 0.00% | 0.0% |
| Q4 2013 | $197,000 | -32.3% | 22,256 | -42.9% | 0.00% | -57.1% |
| Q2 2013 | $291,000 | – | 38,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,020,583 | $15,053,000 | 1.77% |
| Piermont Capital Management Inc. | 247,882 | $1,847,000 | 0.53% |
| BARD ASSOCIATES INC | 129,380 | $964,000 | 0.44% |
| Sonora Investment Management, LLC | 239,202 | $1,782,055,000 | 0.34% |
| TFS CAPITAL LLC | 97,526 | $727,000 | 0.28% |
| Alambic Investment Management, L.P. | 165,001 | $1,229,000 | 0.15% |
| KENNEDY CAPITAL MANAGEMENT LLC | 491,075 | $3,659,000 | 0.07% |
| Renaissance Technologies | 6,071,817 | $45,235,000 | 0.06% |
| Granite Investment Partners, LLC | 97,023 | $723,000 | 0.05% |
| ClariVest Asset Management LLC | 241,909 | $1,802,000 | 0.04% |